Net Income (Loss) Per Share - Summary of Diluted Net Loss Per Share (Details)	6 Months Ended
	Jun. 30, 2022 shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential Common Stock Equivalents (in shares)	329,753,808
Class B
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential Common Stock Equivalents (in shares)	264,527,434
Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential Common Stock Equivalents (in shares)	15,389,953
Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential Common Stock Equivalents (in shares)	12,876,693
Contingent Shares Issued in Connection with Acquisitions
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential Common Stock Equivalents (in shares)	2,720,966
ESPP Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential Common Stock Equivalents (in shares)	705,570
Public Warrants | Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential Common Stock Equivalents (in shares)	22,999,900
Private Placement Warrants | Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Potential Common Stock Equivalents (in shares)	10,533,292